Works matching IS 00283835 AND DT 2017 AND VI 106 AND IP 1

Results: 8
    1
    2

    The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53<sup>wild type</sup> Neuroendocrine Tumor Cell Line GOT1.

    Published in:
    Neuroendocrinology, 2017, v. 106, n. 1, p. 1, doi. 10.1159/000453369
    By:
    • Reuther, Clemens;
    • Heinzle, Vera;
    • Nölting, Svenja;
    • Herterich, Sabine;
    • Hahner, Stefanie;
    • Halilovic, Ensar;
    • Jeay, Sébastien;
    • Wuerthner, Jens U.;
    • Prada, Elke Tatjana Aristizabal;
    • Spöttl, Gerald;
    • Maurer, Julian;
    • Auernhammer, Christoph J.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).

    Published in:
    Neuroendocrinology, 2017, v. 106, n. 1, p. 38, doi. 10.1159/000457955
    By:
    • Roquin, Guillaume;
    • Baudin, Eric;
    • Lombard-Bohas, Catherine;
    • Cadiot, Guillaume;
    • Dominguez, Sophie;
    • Guimbaud, Rosine;
    • Niccoli, Patricia;
    • Legoux, Jean-Louis;
    • Mitry, Emmanuel;
    • Rohmer, Vincent;
    • Ruszniewski, Philippe;
    • Walter, Thomas;
    • Ducreux, Michel;
    • Couvelard, Anne;
    • Scoazec, Jean-Yves;
    • Ramond-Roquin, Aline;
    • Caroli-Bosc, François-Xavier;
    • Hentic, Olivia
    Publication type:
    Article